The Medicare prescription drug plan market appears to be under a lot of stress. And taxpayers are forking over record amounts ...

Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...

Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

After years of counseling families through loss, I am still moved by their strength. I carry with me Eleanor’s prayer, ...

Researchers hoped they had finally found a way to get gene therapies past the blood-brain barrier. Then the first patient ...

A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too ...

There is often less than a minute to review an order before falling behind,” and that makes it harder to catch potential ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

The federal government has sent a record $16 billion to health insurers that sell Medicare drug plans, a flashing red sign ...